CELLECT BIOTECHNOLOGY LTD's ticker is and the CUSIP is 15116C300. A total of 8 filers reported holding CELLECT BIOTECHNOLOGY LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $22,000 | – | 1,213 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 36,291 | $670,000 | 0.00% |
| Charter Oak Capital Management, LLC | 25 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 177 | $3,000 | 0.00% |
| HUNTINGTON NATIONAL BANK | 125 | $2,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 13,003 | $240,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 19 | $0 | 0.00% |
| MORGAN STANLEY | 1,213 | $22,000 | 0.00% |